CD70-targeted immunoPET Imaging of Kidney Cancer

Clinical trial NCT06680089 · RECRUITING

Trial details

NCT number: NCT06680089
Sponsor: RenJi Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urologic Neoplasms Urogenital Neoplasms Kidney Neoplasms Neoplasms

Start date: 2024-11-27
Primary completion: 2026-11-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.